Cerity Partners’s Rockwell Medical RMTI Stock Holding History

Cerity Partners’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-136	Closed	-$15K	–	735
2020 Q4	$15K	Sell	136 -137	-50%	-$15.3K	﹤0.01%	638
2020 Q3	$32K	Buy	+273	New	+$47.2K	﹤0.01%	497

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Cerity Partners's RMTI Position: Q1 2021 in Review

Cerity Partners sold out of Rockwell Medical (RMTI) in Q1 2021, closing a stake of 136 shares — an estimated $15K sold.

Cerity Partners first reported a position in RMTI in Q3 2020 and held it in 2 quarters. The position peaked at $32K in Q3 2020. 89 funds tracked by Wall St. Rank hold RMTI as of Q1 2021.

Cerity Partners reported no remaining Rockwell Medical position as of Q1 2021 after selling out during the quarter.
Cerity Partners sold 136 Rockwell Medical shares in Q1 2021, an estimated $15K.
Cerity Partners first reported a position in Rockwell Medical in Q3 2020 and held it in 2 quarters.
Cerity Partners's Rockwell Medical position peaked at $32K in Q3 2020.
89 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2021.

Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.